Stock Events

Stock Events

BridgeBio Pharma (2CL.XETRA) Q3 2026 Earnings

10AugConfirmed

Q2 2026

Q3 2026

-0.72

-0.64

-0.57

-0.5

Details

Expected EPS

-0.49856999459999995

Actual EPS

-0.675636

Surprise EPS

-0.18

Surprise Percent

+35.51%

Description

BridgeBio Pharma (2CL.XETRA) has reported earnings of -0.675636 per share for Q3 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.